Affordable Access

Access to the full text

Advances in Multiple Sclerosis Research–Series I

Authors
  • Apostolopoulos, Vasso
  • Matsoukas, John1, 2
  • 1 NewDrug, Patras Science Park, 26500 Patras, Greece
  • 2 Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
Type
Published Article
Journal
Brain Sciences
Publisher
MDPI AG
Publication Date
Oct 29, 2020
Volume
10
Issue
11
Identifiers
DOI: 10.3390/brainsci10110795
PMID: 33137992
PMCID: PMC7692630
Source
PubMed Central
Keywords
Disciplines
  • Editorial
License
Green

Abstract

Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular, multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue, “Advances in Multiple Sclerosis Research—Series I”, focused on delivery methods used for immunotherapeutic approaches, drug design, anti-inflammatories, identification of markers, methods for detection and monitoring MS and treatment modalities. The issue gained much attention with 20 publications, and, as a result, we launched Series II with the deadline for submission being 30 April 2021.

Report this publication

Statistics

Seen <100 times